Crowdonomics
WatchlistPortfolio
All companies
CureLab Veterinary logo

CureLab Veterinary

Operating

CureLab Veterinary Inc.

Healthcare · Founded 2020

Visit website

P62 plasmid technology poised to revolutionize cancer treatment in dogs and cats

Post-money valuation ⓘ
$32.8M
As of Apr 2023 · from Reg CF Offering (2022) · pre-money + amount raised, not a traded price
Total raised
$2,629,540
Crowd $130K · Private $2.5M · 2 rounds since 2022
Latest share price
$30.00
Reg CF · Common Stock · Dec 2022 offering price

Financials

FY2020–FY2021 · from SEC filings · hover any figure for its source
$0
−$1K
2020
$0
−$450
2021
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020 reviewed
FY2021 reviewed
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$1,136
-$450
Taxes paid
$0
$0
Balance sheet
Cash
$0
$0
Accounts receivable
$0
$0
Total assets
$0
$0
Short-term debt
$0
$252,544
Long-term debt
$0
$0
Total liabilities
$0
$252,544
Other
Headcount
—
0

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$32.7M
pre-money
Reg CF · Common · Dec 2022

Blue bars are the pre-money valuation the company stated for a priced round.

Fundraising history

Reg CF · Common Stock · Dec 2022Closedvia Netcapital
Raised $129.5K / $1.2MPost-money $32.8M
Rule 506(b) · Equity · Aug 2022Closed
Raised $2.5MInvestors 1

Team

3 people
Alexander Shneider
Board Member
Jason Payne
Principal Financial Officer
Robert Devlin
Principal Executive Officer

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Delinquent

Filed 0 of 4 annual reports (FY2022–FY2025)

Missing: 2022, 2023, 2024, 2025

1 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-USep 1, 20230001669191-23-000822
    EDGAR
  • Form C/AMay 9, 20230001669191-23-000474
    EDGAR
  • Form C/AApr 28, 20230001669191-23-000387
    EDGAR
  • Form C/AMar 22, 20230001669191-23-000270
    EDGAR
  • Form C/AFeb 9, 20230001669191-23-000133
    EDGAR
  • Form CDec 22, 20220001669191-22-001174
    EDGAR
  • Form DDec 21, 20220001080368-22-000052
    EDGAR
Source: ManualCIK 0001934349Share price $30.00

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.